type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: To be eligible to participate in this study, a subject must meet all the following criteria: 1. During the information session, health is assessed by the: a. Screening questionnaire (P9885 F02; in Dutch) 2. During the health check, blood measurements are assessed by the point-of-care tool: a. HbA1c: 39 - 53 mmol/mol (= 5.7 - 7.0%) 3. Age between 18 - 70 years 4. Stable BMI of 25 - 35 kg/m2 5. Informed consent signed 6. Willing to comply with the study procedures during the study 7. Being able to become more physically active, as assessed by the screening questionnaire (P9885 F02; in Dutch). 8. Being digitally competent 9. Willing to accept the use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Being diagnosed with diabetes type 1 or 2 2. Use of insulin, corticosteroids (systemic), or beta-blockers in past month 3. Use of oral diabetes medication in past year 4. (Having a history of a) medical condition that might significantly affect the study outcome as judged by the general practitioner and health and lifestyle questionnaire. This includes gastrointestinal dysfunction, diseases related to inflammation or allergy, or a psychiatric disorder 5. Being abroad or on vacation for longer than a week. 6. Alcohol consumption > 21 (women) - 28 (men) units/week 7. Reported unexplained weight loss or gain of > 2 kg in the month prior to the pre-study screening 8. Recent blood donation (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c as marker for prediabetes risk | — |
Secondary
| Measure | Time frame |
|---|---|
| blood lipids (HDL, LDL, total cholesterol) Blood pressure anthropometrics body composition habitual food intake compliance | — |
Countries
Netherlands